European Journal of Obstetrics & Gynecology and Reproductive Biology
Volume 151, Issue 1 , Pages 96-100 , July 2010

Prevalence of cysts in epithelial ovarian cancer

  • Eva Kolwijck

      Affiliations

    • Radboud University Nijmegen Medical Centre, Department of Obstetrics and Gynecology, Nijmegen, The Netherlands
    • Corresponding Author InformationCorresponding author at: Department of Obstetrics and Gynecology, PO Box 9101, 6500 HB Nijmegen, The Netherlands. Tel.: +31 24 3615125; fax: +31 24 3668597.
    • ,
  • Charlotte Lybol

      Affiliations

    • Radboud University Nijmegen Medical Centre, Department of Obstetrics and Gynecology, Nijmegen, The Netherlands
    • ,
  • Johan Bulten

      Affiliations

    • Radboud University Nijmegen Medical Centre, Department of Pathology, Nijmegen, The Netherlands
    • ,
  • Jos H.A. Vollebergh

      Affiliations

    • Bernhoven Hospital, Department of Obstetrics and Gynecology, Veghel, The Netherlands
    • ,
  • Ron A. Wevers

      Affiliations

    • Radboud University Nijmegen Medical Centre, Laboratory of Pediatrics and Neurology, Nijmegen, The Netherlands
    • ,
  • Leon F.A.G. Massuger

      Affiliations

    • Radboud University Nijmegen Medical Centre, Department of Obstetrics and Gynecology, Nijmegen, The Netherlands

Received 9 September 2009 ,Revised 18 January 2010 ,Accepted 21 February 2010.

References 

  1. Colombo N, Van Gorp T, Parma G, et al. Ovarian cancer. Crit Rev Oncol Hematol. 2006;60:159–179
  2. Tingulstad S, Skjeldestad FE, Halvorsen TB, Hagen B. Survival and prognostic factors in patients with ovarian cancer. Obstet Gynecol. 2003;101:885–891
  3. Howells RE, Dhar KK, Hoban PR, et al. Association between glutathione-S-transferase GSTP1 genotypes, GSTP1 over-expression, and outcome in epithelial ovarian cancer. Int J Gynecol Cancer. 2004;14:242–250
  4. Kurman RJ. Blaustein's pathology of the female genital tract. 5th ed.. New York: Springer-Verlag; 2002;
  5. Bar JK, Harlozinska A, Sobanska E, Cislo M. Relation between ovarian carcinoma-associated antigens in tumor tissue and detached cyst fluid cells of patients with ovarian neoplasms. Tumori. 1994;80:50–55
  6. Boss EA, Massuger LF, Thomas CM, Geurts-Moespot A, Boonstra H, Sweep CG. Vascular endothelial growth factor in ovarian cyst fluid. Cancer. 2001;91:371–377
  7. Kolwijck E, Zusterzeel PL, Roelofs HM, Hendriks JC, Peters WH, Massuger LF. GSTP1-1 in ovarian cyst fluid and disease outcome of patients with ovarian cancer. Cancer Epidemiol Biomarkers Prev. 2009;18:2176–2181
  8. Seidman JD, Soslow RA, Vang R, et al. Borderline ovarian tumors: diverse contemporary viewpoints on terminology and diagnostic criteria with illustrative images. Hum Pathol. 2004;35(8):918–933
  9. Servov SF, Scully RE, Sobin LH. International histologic classification of tumors. No. 9: histologic typing of ovarian tumors. Geneva: World Health Organization; 1973;
  10. International Federation of Gynecology and Obstetrics. Classification and staging of malignant tumours in the female pelvis. Acta Obstet Gynecol Scand 1971;50:1–7.
  11. Scully RE, Sobin LH. Histological typing of ovarian tumours. Berlin/New York: Springer; 1999;p. 9
  12. Silverberg SG. Histopathologic grading of ovarian carcinoma: a review and proposal. Int J Gynecol Pathol. 2000;19:7–15
  13. Benedet JL, Bender H, Jones H, Ngan HY, Pecorelli S. FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers. FIGO Committee on Gynecologic Oncology. Int J Gynaecol Obstet. 2000;70:209–262
  14. Eisenhauer EA, Gore M, Neijt JP. Ovarian cancer: should we be managing patients with good and bad prognostic factors in the same manner?. Ann Oncol. 1999;10(Suppl 1):9–15
  15. Kang WD, Choi HS, Kim SM. Value of serum CA125 levels in patients with high-risk, early stage epithelial ovarian cancer. Gynecol Oncol. 2010;116:57–60
  16. Young RC, Walton LA, Ellenberg SS, et al. Adjuvant therapy in stage I and stage II epithelial ovarian cancer. Results of two prospective randomized trials. N Engl J Med. 1990;322:1021–1027
  17. Shih I, Kurman RJ. Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis. Am J Pathol. 2004;164:1511–1518
  18. Naora H. The heterogeneity of epithelial ovarian cancers: reconciling old and new paradigms. Expert Rev Mol Med. 2007;9:1–12
  19. Vernooij F, Heintz AP, Coebergh JW, Massuger LF, Witteveen PO, van der Graaf Y. Specialized and high-volume care leads to better outcomes of ovarian cancer treatment in The Netherlands. Gynecol Oncol. 2009;112:455–461
  20. Heintz AP, Odicino F, Maisonneuve P, et al. Carcinoma of the ovary. J Epidemiol Biostat. 2001;6:107–138

PII: S0301-2115(10)00110-7

doi: 10.1016/j.ejogrb.2010.02.044

European Journal of Obstetrics & Gynecology and Reproductive Biology
Volume 151, Issue 1 , Pages 96-100 , July 2010

Article Tools